Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies
Go back to Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies| (NASDAQ: AUTL) | Delayed: 1.93 -0.01 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.94 | 52 Week High | $ | |||
| Open | $1.95 | 52 Week Low | $ | |||
| Day High | $1.96 | P/E | N/A | |||
| Day Low | $1.91 | EPS | $ | |||
| Volume | 298,701 | |||||

